Stay updated on BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No study content or user-facing features were altered.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded related topics 'Multiple Myeloma' and 'MedlinePlus Genetics'. Updated the footer to Revision: v3.4.1.SummaryDifference0.2%

- Check19 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics; updated revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange Detected- The page no longer displays 'Multiple myeloma' and related 'MedlinePlus Genetics' topics. This reduces disease-specific navigation and contextual resources for users.SummaryDifference0.2%

- Check41 days agoChange DetectedThe update includes a minor CMS revision (Revision: v3.3.4) and related topic links (e.g., MedlinePlus Genetics) with the page emphasizing Multiple Myeloma; core trial content and enrollment criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange Detected- The page now includes a Locations section showing the New York site (Memorial Sloan Kettering Cancer Center). - This adds location-specific details for the study page.SummaryDifference0.4%

Stay in the know with updates to BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.